Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CHE NYSE:DGX NYSE:DVA NYSE:LH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEChemed$452.36-2.1%$450.29$408.42▼$623.60$6.59B0.46145,125 shs125,977 shsDGXQuest Diagnostics$188.83-0.1%$178.61$146.17▼$189.48$21.12B0.541.10 million shs525,381 shsDVADaVita$130.66-0.1%$136.16$126.07▼$179.60$9.34B1.13853,447 shs481,649 shsLHLabcorp$282.65+0.7%$271.17$209.38▼$283.47$23.49B0.85682,202 shs439,984 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEChemed0.00%+2.24%+0.80%-4.72%-22.83%DGXQuest Diagnostics0.00%+3.00%+4.06%+5.39%+22.22%DVADaVita0.00%+0.87%-4.81%-7.95%-19.62%LHLabcorp0.00%+1.37%+1.01%+7.04%+26.46%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEChemed$452.36-2.1%$450.29$408.42▼$623.60$6.59B0.46145,125 shs125,977 shsDGXQuest Diagnostics$188.83-0.1%$178.61$146.17▼$189.48$21.12B0.541.10 million shs525,381 shsDVADaVita$130.66-0.1%$136.16$126.07▼$179.60$9.34B1.13853,447 shs481,649 shsLHLabcorp$282.65+0.7%$271.17$209.38▼$283.47$23.49B0.85682,202 shs439,984 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEChemed0.00%+2.24%+0.80%-4.72%-22.83%DGXQuest Diagnostics0.00%+3.00%+4.06%+5.39%+22.22%DVADaVita0.00%+0.87%-4.81%-7.95%-19.62%LHLabcorp0.00%+1.37%+1.01%+7.04%+26.46%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHEChemed 3.00Buy$578.5027.88% UpsideDGXQuest Diagnostics 2.50Moderate Buy$186.00-1.50% DownsideDVADaVita 1.75Reduce$158.0020.92% UpsideLHLabcorp 2.62Moderate Buy$290.332.72% UpsideCurrent Analyst Ratings BreakdownLatest CHE, LH, DGX, and DVA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/10/2025CHEChemedBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$610.00 ➝ $595.009/10/2025DVADaVitaBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetUnderperform$145.00 ➝ $140.009/2/2025CHEChemedJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$490.00 ➝ $550.008/25/2025LHLabcorpRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$311.008/25/2025DGXQuest DiagnosticsBaird R WSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/25/2025DGXQuest DiagnosticsRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform ➝ Neutral$194.008/8/2025DVADaVitaTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$148.008/7/2025DVADaVitaBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$169.00 ➝ $160.007/31/2025CHEChemedRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$640.00 ➝ $589.007/31/2025CHEChemedOppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$650.00 ➝ $580.007/25/2025CHEChemedJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageHold$500.00(Data available from 9/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHEChemed$2.43B2.71$25.16 per share17.98$74.35 per share6.08DGXQuest Diagnostics$9.87B2.14$13.50 per share13.99$61.38 per share3.08DVADaVita$12.82B0.73$19.10 per share6.84$4.83 per share27.05LHLabcorp$13.01B1.81$22.58 per share12.52$96.27 per share2.94Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHEChemed$302M$19.4523.2619.412.6911.56%25.83%17.77%11/4/2025 (Estimated)DGXQuest Diagnostics$871M$8.3522.6118.002.519.01%15.24%6.64%10/21/2025 (Estimated)DVADaVita$936.34M$10.1712.8510.280.946.35%369.39%4.62%11/4/2025 (Estimated)LHLabcorp$746M$9.0631.2016.111.795.66%15.45%7.02%10/28/2025 (Estimated)Latest CHE, LH, DGX, and DVA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/23/2025Q3 2025LHLabcorp$4.12N/AN/AN/A$3.56 billionN/A10/21/2025Q3 2025DGXQuest Diagnostics$2.51N/AN/AN/A$2.73 billionN/A8/5/2025Q2 2025DVADaVita$2.70$2.95+$0.25$2.58$3.36 billion$3.38 billion7/29/2025Q2 2025CHEChemed$6.02$4.27-$1.75$3.57$650.60 million$618.80 million7/24/2025Q2 2025LHLabcorp$4.14$4.35+$0.21$2.84$3.49 billion$3.53 billion7/22/2025Q2 2025DGXQuest Diagnostics$2.57$2.62+$0.05$2.47$2.73 billion$2.76 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHEChemed$2.400.53%N/A12.34%16 YearsDGXQuest Diagnostics$3.201.69%N/A38.32%14 YearsDVADaVitaN/AN/AN/AN/AN/ALHLabcorp$2.881.02%N/A31.79%N/ALatest CHE, LH, DGX, and DVA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/13/2025DGXQuest Diagnosticsquarterly$0.801.79%10/3/202510/3/202510/20/20257/10/2025LHLabcorpquarterly$0.721.05%8/28/20258/28/20259/11/20258/1/2025CHEChemedquarterly$0.600.6%8/11/20258/11/20258/29/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHEChemedN/A1.861.83DGXQuest Diagnostics0.711.090.99DVADaVita23.181.391.34LHLabcorp0.611.501.32Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHEChemed95.85%DGXQuest Diagnostics88.06%DVADaVita90.12%LHLabcorp95.94%Insider OwnershipCompanyInsider OwnershipCHEChemed3.29%DGXQuest Diagnostics8.16%DVADaVita1.50%LHLabcorp0.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHEChemed15,69514.57 million14.09 millionOptionableDGXQuest Diagnostics56,000111.82 million102.70 millionOptionableDVADaVita76,00071.50 million70.43 millionOptionableLHLabcorp70,00083.10 million82.40 millionOptionableCHE, LH, DGX, and DVA HeadlinesRecent News About These CompaniesPatton Fund Management Inc. Invests $253,000 in Labcorp Holdings Inc. $LHSeptember 28 at 5:13 AM | marketbeat.comPublic Employees Retirement System of Ohio Has $7.99 Million Position in Labcorp Holdings Inc. $LHSeptember 28 at 4:51 AM | marketbeat.comA Closer Look at Labcorp Holdings (LH) Valuation as Growth Steadily ContinuesSeptember 27 at 2:11 PM | finance.yahoo.comLabcorp Holdings Inc. $LH Shares Sold by Dakota Wealth ManagementSeptember 27 at 3:47 AM | marketbeat.comLabcorp Holdings Inc. $LH Shares Sold by Park Avenue Securities LLCSeptember 26 at 4:06 AM | marketbeat.comLabcorp Holdings to Release Q3 2025 Financial ResultsSeptember 25, 2025 | tipranks.comLabcorp to Announce Third Quarter Financial Results on October 28, 2025September 25, 2025 | prnewswire.comLabcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?September 24, 2025 | zacks.comBanyan Capital Management Inc. Purchases 923 Shares of Labcorp Holdings Inc. $LHSeptember 24, 2025 | marketbeat.comLabcorp (NYSE:LH) Hits New 12-Month High - Here's WhySeptember 23, 2025 | marketbeat.comReasons to Add Labcorp Stock to Your Portfolio Right NowSeptember 23, 2025 | zacks.comCardinal Capital Management Has $9.93 Million Stock Holdings in Labcorp Holdings Inc. $LHSeptember 23, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Increases Position in Labcorp Holdings Inc. $LHSeptember 23, 2025 | marketbeat.comLabcorp Holdings Stock: Is LH Outperforming the Healthcare Sector?September 22, 2025 | msn.com3 Mid-Cap Stocks with Warning SignsSeptember 22, 2025 | msn.comLabcorp Holdings Inc. $LH Stock Position Boosted by Assenagon Asset Management S.A.September 22, 2025 | marketbeat.comWedge Capital Management L L P NC Reduces Stock Position in Labcorp Holdings Inc. $LHSeptember 21, 2025 | marketbeat.comBusey Bank Has $16.41 Million Stake in Labcorp Holdings Inc. $LHSeptember 21, 2025 | marketbeat.comBDF Gestion Sells 1,074 Shares of Labcorp Holdings Inc. $LHSeptember 21, 2025 | marketbeat.comLabcorp Holdings Inc. (NYSE:LH) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesSeptember 21, 2025 | americanbankingnews.comLabcorp Holdings Inc. (NYSE:LH) Given Average Recommendation of "Moderate Buy" by AnalystsSeptember 21, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesInsiders Sell These High-Quality Stocks: Why Investors Shouldn’tBy Thomas Hughes | September 8, 2025These 3 Tech Stocks Just Supercharged Their BuybacksBy Leo Miller | September 16, 2025Broadcom Price Targets Just Reached Above $400 for the First TimeBy Leo Miller | September 24, 20253 Stocks Positioned to Win With Strong Recurring Revenue StreamsBy Nathan Reiff | September 15, 20253 Under-the-Radar Biotechs Under $5 That Could Soar 200%By Chris Markoch | September 9, 2025CHE, LH, DGX, and DVA Company DescriptionsChemed NYSE:CHE$452.36 -9.87 (-2.13%) Closing price 03:59 PM EasternExtended Trading$453.88 +1.52 (+0.34%) As of 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Quest Diagnostics NYSE:DGX$188.83 -0.16 (-0.08%) Closing price 03:59 PM EasternExtended Trading$189.26 +0.43 (+0.23%) As of 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$130.66 -0.14 (-0.11%) Closing price 03:59 PM EasternExtended Trading$130.61 -0.05 (-0.04%) As of 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Labcorp NYSE:LH$282.65 +2.04 (+0.73%) Closing price 03:59 PM EasternExtended Trading$282.78 +0.13 (+0.05%) As of 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Top-Rated Dividend Growth Stocks to Buy in October Top Insider Buys and Sells From September: Buy, Sell, or Hold? MarketBeat Week in Review – 09/22 - 09/26 Get Exposure to Millennials' Purchasing Power With This ETF Beam Global Gets Buy Rating With 101% Upside Potential Institutional Buying Sets a High Floor for Microsoft Stock High-Momentum ETFs to Mine for Gold, Silver, and Bitcoin ASML Is a Hidden Gem in This Technology Rally, a Catch Up Play Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
